Equities Analysts Issue Forecasts for INSP FY2024 Earnings

Inspire Medical Systems, Inc. (NYSE:INSP) – Equities researchers at Leerink Partnrs decreased their FY2024 EPS estimates for shares of Inspire Medical Systems in a research report issued to clients and investors on Monday, November 25th. Leerink Partnrs analyst M. Kratky now anticipates that the company will post earnings of $1.37 per share for the year, down from their previous estimate of $1.38. The consensus estimate for Inspire Medical Systems’ current full-year earnings is $1.33 per share. Leerink Partnrs also issued estimates for Inspire Medical Systems’ Q2 2025 earnings at $0.40 EPS, Q3 2025 earnings at $0.47 EPS, Q4 2025 earnings at $1.10 EPS, FY2025 earnings at $1.73 EPS and FY2026 earnings at $2.62 EPS.

Other equities analysts have also issued research reports about the company. Truist Financial reissued a “buy” rating and issued a $240.00 price objective (up previously from $217.00) on shares of Inspire Medical Systems in a report on Monday, September 30th. Wells Fargo & Company upped their price objective on Inspire Medical Systems from $187.00 to $198.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 5th. Stifel Nicolaus reaffirmed a “hold” rating and set a $200.00 target price (up from $170.00) on shares of Inspire Medical Systems in a report on Tuesday, November 5th. Piper Sandler reissued an “overweight” rating and set a $260.00 price target (up from $255.00) on shares of Inspire Medical Systems in a report on Tuesday, November 5th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $260.00 price target on shares of Inspire Medical Systems in a research report on Tuesday, November 5th. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $233.58.

Inspire Medical Systems Stock Down 5.2 %

Inspire Medical Systems stock opened at $189.05 on Wednesday. The stock has a 50-day moving average price of $199.01 and a 200 day moving average price of $175.73. The company has a market capitalization of $5.67 billion, a price-to-earnings ratio of 176.68 and a beta of 1.36. Inspire Medical Systems has a 52 week low of $123.00 and a 52 week high of $257.40.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.60 earnings per share for the quarter, topping analysts’ consensus estimates of $0.06 by $0.54. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%. The business had revenue of $203.20 million for the quarter, compared to analyst estimates of $197.59 million. During the same quarter in the previous year, the firm earned ($0.29) earnings per share. The company’s revenue was up 32.6% on a year-over-year basis.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in INSP. SouthState Corp bought a new position in shares of Inspire Medical Systems during the second quarter worth about $27,000. True Wealth Design LLC acquired a new stake in Inspire Medical Systems during the third quarter valued at approximately $30,000. Farther Finance Advisors LLC lifted its holdings in Inspire Medical Systems by 1,158.3% during the 3rd quarter. Farther Finance Advisors LLC now owns 151 shares of the company’s stock worth $32,000 after buying an additional 139 shares during the last quarter. GAMMA Investing LLC lifted its holdings in Inspire Medical Systems by 559.3% during the 3rd quarter. GAMMA Investing LLC now owns 178 shares of the company’s stock worth $38,000 after buying an additional 151 shares during the last quarter. Finally, Quarry LP grew its position in shares of Inspire Medical Systems by 105.4% in the 2nd quarter. Quarry LP now owns 343 shares of the company’s stock worth $46,000 after acquiring an additional 176 shares in the last quarter. 94.91% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Inspire Medical Systems

In other Inspire Medical Systems news, Director Shawn Mccormick sold 800 shares of the company’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $220.00, for a total value of $176,000.00. Following the transaction, the director now directly owns 23,140 shares of the company’s stock, valued at $5,090,800. This represents a 3.34 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 4.10% of the company’s stock.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.